March - 2011
| Previous Next | Showing Journal 3 of 12 |
 Dalteparin versus Unfractionated Heparin in Critically Ill PatientsThe PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group NEJM, 2011, Mar 22,2011 |
March |
Previous Comments
No Comments yet.
Comment
The PROTECT trial is another incredible ANZICS CTG effort, in conjunction with the Canadian CTG. This 3764 participant, double blinded, multicentre, international,...This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register